Compare · MEDS vs TDOC
MEDS vs TDOC
Side-by-side comparison of DataMeds AI Inc. (MEDS) and Teladoc Health Inc. (TDOC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. MEDS focuses on Other Pharmaceuticals, while TDOC focuses on Medical/Nursing Services.
- TDOC is the larger of the two at $1.59B, about 511.3x MEDS ($3.1M).
- TDOC has been more active in the news (10 items in the past 4 weeks vs 6 for MEDS).
- TDOC has more recent analyst coverage (25 ratings vs 1 for MEDS).
- Company
- DataMeds AI Inc.
- Teladoc Health Inc.
- Price
- -
- -
- Market cap
- $3.1M
- $1.59B
- 1M return
- -77.82%
- -
- 1Y return
- -98.02%
- -
- Industry
- Other Pharmaceuticals
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 6
- 10
- Recent ratings
- 1
- 25
DataMeds AI Inc.
DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc., is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC, and its pharmacy-related Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health. DataMEDS also owns Helomics Corporation, a Pittsburgh, PA -based commercial clinical molecular diagnostics laboratory focused on the ChemoFx Assay chemotherapy selection diagnostics test that aims to help oncologists make chemotherapy treatment decisions.
Teladoc Health Inc.
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
Latest MEDS
- UPDATING ORIGINAL RELEASE DataMEDS AI Releases CEO Letter
- DataMEDS AI Releases CEO Letter
- DataMEDS AI Reports 50% Sequential Revenue Growth in Third Quarter 2026 From Second Quarter 2026, Delivers Net Profit Per Share of $2.72 and Provides Business Update
- DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
- DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent
- DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
- DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
- Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
- DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
- DataMeds Regains Compliance With NASDAQ Listing Standards
Latest TDOC
- SEC Form SCHEDULE 13G filed by Teladoc Health Inc.
- President, International Nueno Carlos sold $270,774 worth of shares (29,432 units at $9.20) as part of a pre-agreed trading plan, decreasing direct ownership by 45% to 35,312 units (SEC Form 4)
- Gabelli Releases Agenda for 8th Annual Healthcare Symposium
- New insider Dorfman Jonathan claimed ownership of 2,773 shares (SEC Form 3)
- Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
- Teladoc downgraded by Argus
- SEC Form 10-Q filed by Teladoc Health Inc.
- SEC Form 8-K filed by Teladoc Health Inc.
- Teladoc Health Reports Third Quarter 2026 Results
- Gabelli To Host 8th Annual Healthcare Symposium